Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase 1/2 2Phase 1 2Phase 2/3 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 2NETWORK 2INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 14Ovarian Neoplasms 6Neoplasms 5Liposarcoma 5Leiomyosarcoma 5Liposarcoma, Myxoid 3Breast Neoplasms 3Sarcoma, Ewing 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Osteosarcoma 2Neoplasms by Site 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Ichthyosis, X-Linked 2Endometrial Neoplasms 2Uterine Neoplasms 1Solitary Fibrous Tumors 1Soft Tissue Neoplasms 1Skin Diseases 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Recurrent High Grade Meningioma 1Pancreatic Neoplasms 1Ovarian Diseases 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Mesothelioma 1Malignant mesenchymal tumor 1

Interventions

Gemcitabine 13Doxorubicin 8Docetaxel 7Trabectedin 5pazopanib 4Nivolumab 4Temozolomide 3Specimen Handling 3Sorafenib 3rucaparib 2pembrolizumab 2liposomal doxorubicin 2durvalumab 2brostallicin 2Sunitinib 2Radiotherapy 2Radiation Dose Hypofractionation 2Magnetic Resonance Spectroscopy 2Letrozole 2Ifosfamide 2Dacarbazine 2Bevacizumab 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2tremelimumab 1talimogene laherparepvec 1sotigalimab 1soblidotin 1saracatinib 1rubitecan 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Leiomyosarcoma × Trabectedin × Clear all
NCT04535271 2025-02-24

TAGGED

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
80 enrolled
Sarcoma

Leiomyosarcoma

NCT02247544 2021-11-01

TRAVELL

Italian Sarcoma Group

Phase 2 Completed
105 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Ichthyosis, X-Linked

NCT02249702 2017-12-06

TAUL

Mario Negri Institute for Pharmacological Research

Phase 2 Completed
168 enrolled
Sarcoma

Leiomyosarcoma

NCT00060944 2014-09-08

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
271 enrolled 13 charts
Sarcoma

Leiomyosarcoma, Liposarcoma, Neoplasm Metastasis, Neoplasms

NCT00003939 2012-09-24

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
132 enrolled
CNSGastrointestinalGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Central Nervous System Neoplasms, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡